Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages

  Bae, Sun Hyun ^a   Kim, Mi Sook ^a   Cho, Chul Koo ^a   Kang, Jin Kyu ^a   Lee, Sang Yeob ^a   Lee, Kyung Nam ^a   Lee, Dong Han ^a   Han, Chul Ju ^a   Yang, Ki Young ^a   Kim, Sang Bum ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DOSIMETRY; PATIENT MONITORING; TOXICITY;

CLINICAL PREDICTORS; CLINICAL RECORDS; DOSIMETRIC PARAMETER; ELIGIBILITY CRITERION; METHODS AND MATERIALS; NATIONAL CANCER INSTITUTE; STEREOTACTIC BODY RADIOTHERAPY; UNIVARIATE ANALYSIS;

RADIOTHERAPY;

ABDOMINAL CANCER; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COLORECTAL CANCER; DISEASE COURSE; DISEASE SEVERITY; DOSIMETRY; DUODENUM DISEASE; DUODENUM ULCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PANPERITONITIS; PARAAORTIC LYMPH NODE; PELVIS CANCER; PERITONITIS; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE FRACTIONATION; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STEREOTACTIC BODY RADIATION THERAPY; STOMACH CANCER; STOMACH PERFORATION; STOMACH ULCER; TUMOR LOCALIZATION; UTERINE CERVIX CANCER; ABDOMINAL TUMOR; ANALYSIS OF VARIANCE; COMPUTER ASSISTED RADIOTHERAPY; DUODENUM; METHODOLOGY; MIDDLE AGED; ORGANS AT RISK; PATHOLOGY; PELVIS TUMOR; RADIATION EXPOSURE; RADIOSURGERY; RETROSPECTIVE STUDY; STOMACH; TIME; TUMOR VOLUME;

ABDOMINAL NEOPLASMS; ADULT; AGED; ANALYSIS OF VARIANCE; DOSE FRACTIONATION; DUODENUM; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANS AT RISK; PELVIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; ROC CURVE; STOMACH; TIME FACTORS; TUMOR BURDEN;

EID: 84872018368     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.06.005     Document Type: Article

References (22)

1. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60:1026-1032.
2. Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951; 102:316-319.
3. Khrizman P, Small W Jr., Dawson L, et al. The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings. Clin Colorectal Cancer 2010; 9: 136-143.
4. Choi CW, Cho CK, Yoo SY, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 2009; 74:147-153.
5. Kim MS, Yoo SY, Cho CK, et al. Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009; 24:488-492.
6. Kang JK, Kim MS, Kim JH, et al. Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 2010; 27: 273-278.
7. Seo YS, Kim MS, Yoo SY, et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepa-tocellular carcinoma. J Surg Oncol 2010; 102:209-214.
8. Bae SH, Kim MS, Cho CK, et al. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases. J Surg Oncol 2012; 106:138-143.
9. Kang JK, Kim MS, Cho CK, et al. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete TACE: A single institution phase II trial. Cancer 2012.
10. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995; 31: 1213-1236.
11. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985; 8:S13-S19.
12. Mittelhammer R. The method of maximum likelihood in mathematical statistics for economics and business. New York: Springer; 1996.
13. Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008; 18:215-222.
14. Hoyer M, Roed H, Sengelov L, et al. Phase II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005; 76:48-53.
15. Kavanagh BD, Schefter TE, Cardenes HR, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006; 45:848-855.
16. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27:1572-1578.
17. Kopek N, Holt MI, Hansen AT, et al. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010; 94:47-52.
18. Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70:847-852.
19. Mendez Romero A, Zinkstok RT, Wunderink W, et al. Stereotactic body radiation therapy for liver tumors: impact of daily setup corrections and day-to-day anatomic variations on dose in target and organs at risk. Int J Radiat Oncol Biol Phys 2009; 75:1201-1208.
20. Murphy JD, Christman-Skieller C, Kim J, et al. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2010; 78:1420-1426.
21. Kitano S, Dolgor B. Does portal hypertension contribute to the path-ogenesis of gastric ulcer associated with liver cirrhosis? J Gastro-enterol 2000; 35:79-86.
22. Gupta R, Sawant P, Parameshwar RV, et al. Gastric mucosal blood flow and hepatic perfusion index in patients with portal hypertensive gastropathy. J Gastroenterol Hepatol 1998; 13:921-926.